These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33868498)

  • 1. Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis.
    Kohs TCL; Lorentz CU; Johnson J; Puy C; Olson SR; Shatzel JJ; Gailani D; Hinds MT; Tucker EI; Gruber A; McCarty OJT; Wallisch M
    Cell Mol Bioeng; 2021 Apr; 14(2):161-175. PubMed ID: 33868498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates.
    Wallisch M; Lorentz CU; Lakshmanan HHS; Johnson J; Carris MR; Puy C; Gailani D; Hinds MT; McCarty OJT; Gruber A; Tucker EI
    Res Pract Thromb Haemost; 2020 Feb; 4(2):205-216. PubMed ID: 32110750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody.
    Frunt R; El Otmani H; Smits S; Clark CC; Maas C
    J Thromb Haemost; 2024 Sep; 22(9):2562-2575. PubMed ID: 38897387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T; Nieswandt B; Gailani D
    Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow.
    Keeling NM; Wallisch M; Johnson J; Le HH; Vu HH; Jordan KR; Puy C; Tucker EI; Nguyen KP; McCarty OJT; Aslan JE; Hinds MT; Anderson DEJ
    J Thromb Haemost; 2024 May; 22(5):1433-1446. PubMed ID: 38331196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a humanized FXII knock-in mouse-A powerful model system to test novel anti-thrombotic agents.
    Beck S; Stegner D; Loroch S; Baig AA; Göb V; Schumbrutzki C; Eilers E; Sickmann A; May F; Nolte MW; Panousis C; Nieswandt B
    J Thromb Haemost; 2021 Nov; 19(11):2835-2840. PubMed ID: 34363738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
    Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in vivo.
    Chaudhry SA; Serrata M; Tomczak L; Higgins S; Ryu J; Laprise D; Enjyoji K; Bekendam R; Kaushik V; Flaumenhaft R; Bendapudi PK
    J Thromb Haemost; 2020 Sep; 18(9):2318-2328. PubMed ID: 32542960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner.
    White-Adams TC; Berny MA; Patel IA; Tucker EI; Gailani D; Gruber A; McCarty OJ
    J Thromb Haemost; 2010 Jun; 8(6):1295-301. PubMed ID: 20796202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective thrombus formation in mice lacking coagulation factor XII.
    Renné T; Pozgajová M; Grüner S; Schuh K; Pauer HU; Burfeind P; Gailani D; Nieswandt B
    J Exp Med; 2005 Jul; 202(2):271-81. PubMed ID: 16009717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
    Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
    Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor XII contributes to hemostasis when activated by soil in wounds.
    Juang LJ; Mazinani N; Novakowski SK; Prowse ENP; Haulena M; Gailani D; Lavkulich LM; Kastrup CJ
    Blood Adv; 2020 Apr; 4(8):1737-1745. PubMed ID: 32339233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
    Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
    Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Deficiency of Intrinsic Coagulation Factors XI and XII on Ex Vivo Thrombus Formation and Clot Lysis.
    Govers-Riemslag JWP; Konings J; Cosemans JMEM; van Geffen JP; de Laat B; Heemskerk JWM; Dargaud Y; Ten Cate H
    TH Open; 2019 Jul; 3(3):e273-e285. PubMed ID: 31511847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.